Loading…

Sorafenib regulating ERK signals pathway in gastric cancer cell

Highlights • Migration, invasion and apoptosis of SGC7901 were inhibited by sorafenib. • Sorafenib treatment decreased phosphorylation activation of ERK protein. • Sorafenib increased pro-apoptosis protein expression. • ERK signals in SGC7901 are one of the mechanisms of sorafenib inhibiting gastric...

Full description

Saved in:
Bibliographic Details
Published in:Environmental toxicology and pharmacology 2014-09, Vol.38 (2), p.438-443
Main Authors: Juan, Liu Wei, En, Lin Ming, Hao, Lin, Kai, Hong Ying, Ju, Huang
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c411t-453048551536de876f99ed51553f746aa322fc60efaa5351afb819be9e9085b03
cites cdi_FETCH-LOGICAL-c411t-453048551536de876f99ed51553f746aa322fc60efaa5351afb819be9e9085b03
container_end_page 443
container_issue 2
container_start_page 438
container_title Environmental toxicology and pharmacology
container_volume 38
creator Juan, Liu Wei
En, Lin Ming
Hao, Lin
Kai, Hong Ying
Ju, Huang
description Highlights • Migration, invasion and apoptosis of SGC7901 were inhibited by sorafenib. • Sorafenib treatment decreased phosphorylation activation of ERK protein. • Sorafenib increased pro-apoptosis protein expression. • ERK signals in SGC7901 are one of the mechanisms of sorafenib inhibiting gastric cancer.
doi_str_mv 10.1016/j.etap.2014.07.012
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1609098765</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1382668914001665</els_id><sourcerecordid>1609098765</sourcerecordid><originalsourceid>FETCH-LOGICAL-c411t-453048551536de876f99ed51553f746aa322fc60efaa5351afb819be9e9085b03</originalsourceid><addsrcrecordid>eNp9kUFr3DAQhUVp6G62_QM9BB97sTOSLMmGkBJCmpQsBLLtWcjyeKuN195KdsL--8rsJocectII3nvMfI-QrxQyClSebzIczC5jQPMMVAaUfSBzWiiWKlDqY5x5wVIpi3JGTkPYAFDBefGJzJigXCol5-T7qvemwc5Vicf12JrBdevk5vE-CW7dmTYkOzP8eTH7xHXJ2oTBO5tY01n0icW2_UxOmqjCL8d3QX7_uPl1fZcuH25_Xl8tU5tTOqS54JAXQsQFZI2Fkk1ZYh2_gjcql8ZwxhorARtjBBfUNFVBywpLLKEQFfAF-XbI3fn-74hh0FsXpgVMh_0YNJVQQhmDRZSyg9T6PgSPjd55tzV-rynoCZze6AmcnsBpUDqCi6azY_5YbbF-s7ySioKLgwDjlc8OvQ7WYeRQO4920HXv3s-__M9uW9c5a9on3GPY9KOfaGuqA9OgV1N1U3M0j63JeNU_agKSWg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1609098765</pqid></control><display><type>article</type><title>Sorafenib regulating ERK signals pathway in gastric cancer cell</title><source>ScienceDirect Freedom Collection</source><creator>Juan, Liu Wei ; En, Lin Ming ; Hao, Lin ; Kai, Hong Ying ; Ju, Huang</creator><creatorcontrib>Juan, Liu Wei ; En, Lin Ming ; Hao, Lin ; Kai, Hong Ying ; Ju, Huang</creatorcontrib><description>Highlights • Migration, invasion and apoptosis of SGC7901 were inhibited by sorafenib. • Sorafenib treatment decreased phosphorylation activation of ERK protein. • Sorafenib increased pro-apoptosis protein expression. • ERK signals in SGC7901 are one of the mechanisms of sorafenib inhibiting gastric cancer.</description><identifier>ISSN: 1382-6689</identifier><identifier>EISSN: 1872-7077</identifier><identifier>DOI: 10.1016/j.etap.2014.07.012</identifier><identifier>PMID: 25136776</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Antineoplastic Agents - pharmacology ; Apoptosis ; Cell cycle ; Cell Line, Tumor ; Cell Movement - drug effects ; Cell Proliferation - drug effects ; Emergency ; ERK signal pathway ; Gastric cancer ; Gene Expression Regulation, Neoplastic - drug effects ; Humans ; MAP Kinase Signaling System - drug effects ; Microcystis - metabolism ; Niacinamide - analogs &amp; derivatives ; Niacinamide - pharmacology ; Phenylurea Compounds - pharmacology ; Phosphorylation - drug effects ; Protein Kinase Inhibitors - pharmacology ; SGC7901 ; Stomach Neoplasms - drug therapy ; Stomach Neoplasms - genetics</subject><ispartof>Environmental toxicology and pharmacology, 2014-09, Vol.38 (2), p.438-443</ispartof><rights>Elsevier B.V.</rights><rights>2014 Elsevier B.V.</rights><rights>Copyright © 2014 Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c411t-453048551536de876f99ed51553f746aa322fc60efaa5351afb819be9e9085b03</citedby><cites>FETCH-LOGICAL-c411t-453048551536de876f99ed51553f746aa322fc60efaa5351afb819be9e9085b03</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25136776$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Juan, Liu Wei</creatorcontrib><creatorcontrib>En, Lin Ming</creatorcontrib><creatorcontrib>Hao, Lin</creatorcontrib><creatorcontrib>Kai, Hong Ying</creatorcontrib><creatorcontrib>Ju, Huang</creatorcontrib><title>Sorafenib regulating ERK signals pathway in gastric cancer cell</title><title>Environmental toxicology and pharmacology</title><addtitle>Environ Toxicol Pharmacol</addtitle><description>Highlights • Migration, invasion and apoptosis of SGC7901 were inhibited by sorafenib. • Sorafenib treatment decreased phosphorylation activation of ERK protein. • Sorafenib increased pro-apoptosis protein expression. • ERK signals in SGC7901 are one of the mechanisms of sorafenib inhibiting gastric cancer.</description><subject>Antineoplastic Agents - pharmacology</subject><subject>Apoptosis</subject><subject>Cell cycle</subject><subject>Cell Line, Tumor</subject><subject>Cell Movement - drug effects</subject><subject>Cell Proliferation - drug effects</subject><subject>Emergency</subject><subject>ERK signal pathway</subject><subject>Gastric cancer</subject><subject>Gene Expression Regulation, Neoplastic - drug effects</subject><subject>Humans</subject><subject>MAP Kinase Signaling System - drug effects</subject><subject>Microcystis - metabolism</subject><subject>Niacinamide - analogs &amp; derivatives</subject><subject>Niacinamide - pharmacology</subject><subject>Phenylurea Compounds - pharmacology</subject><subject>Phosphorylation - drug effects</subject><subject>Protein Kinase Inhibitors - pharmacology</subject><subject>SGC7901</subject><subject>Stomach Neoplasms - drug therapy</subject><subject>Stomach Neoplasms - genetics</subject><issn>1382-6689</issn><issn>1872-7077</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><recordid>eNp9kUFr3DAQhUVp6G62_QM9BB97sTOSLMmGkBJCmpQsBLLtWcjyeKuN195KdsL--8rsJocectII3nvMfI-QrxQyClSebzIczC5jQPMMVAaUfSBzWiiWKlDqY5x5wVIpi3JGTkPYAFDBefGJzJigXCol5-T7qvemwc5Vicf12JrBdevk5vE-CW7dmTYkOzP8eTH7xHXJ2oTBO5tY01n0icW2_UxOmqjCL8d3QX7_uPl1fZcuH25_Xl8tU5tTOqS54JAXQsQFZI2Fkk1ZYh2_gjcql8ZwxhorARtjBBfUNFVBywpLLKEQFfAF-XbI3fn-74hh0FsXpgVMh_0YNJVQQhmDRZSyg9T6PgSPjd55tzV-rynoCZze6AmcnsBpUDqCi6azY_5YbbF-s7ySioKLgwDjlc8OvQ7WYeRQO4920HXv3s-__M9uW9c5a9on3GPY9KOfaGuqA9OgV1N1U3M0j63JeNU_agKSWg</recordid><startdate>20140901</startdate><enddate>20140901</enddate><creator>Juan, Liu Wei</creator><creator>En, Lin Ming</creator><creator>Hao, Lin</creator><creator>Kai, Hong Ying</creator><creator>Ju, Huang</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20140901</creationdate><title>Sorafenib regulating ERK signals pathway in gastric cancer cell</title><author>Juan, Liu Wei ; En, Lin Ming ; Hao, Lin ; Kai, Hong Ying ; Ju, Huang</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c411t-453048551536de876f99ed51553f746aa322fc60efaa5351afb819be9e9085b03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Antineoplastic Agents - pharmacology</topic><topic>Apoptosis</topic><topic>Cell cycle</topic><topic>Cell Line, Tumor</topic><topic>Cell Movement - drug effects</topic><topic>Cell Proliferation - drug effects</topic><topic>Emergency</topic><topic>ERK signal pathway</topic><topic>Gastric cancer</topic><topic>Gene Expression Regulation, Neoplastic - drug effects</topic><topic>Humans</topic><topic>MAP Kinase Signaling System - drug effects</topic><topic>Microcystis - metabolism</topic><topic>Niacinamide - analogs &amp; derivatives</topic><topic>Niacinamide - pharmacology</topic><topic>Phenylurea Compounds - pharmacology</topic><topic>Phosphorylation - drug effects</topic><topic>Protein Kinase Inhibitors - pharmacology</topic><topic>SGC7901</topic><topic>Stomach Neoplasms - drug therapy</topic><topic>Stomach Neoplasms - genetics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Juan, Liu Wei</creatorcontrib><creatorcontrib>En, Lin Ming</creatorcontrib><creatorcontrib>Hao, Lin</creatorcontrib><creatorcontrib>Kai, Hong Ying</creatorcontrib><creatorcontrib>Ju, Huang</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Environmental toxicology and pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Juan, Liu Wei</au><au>En, Lin Ming</au><au>Hao, Lin</au><au>Kai, Hong Ying</au><au>Ju, Huang</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Sorafenib regulating ERK signals pathway in gastric cancer cell</atitle><jtitle>Environmental toxicology and pharmacology</jtitle><addtitle>Environ Toxicol Pharmacol</addtitle><date>2014-09-01</date><risdate>2014</risdate><volume>38</volume><issue>2</issue><spage>438</spage><epage>443</epage><pages>438-443</pages><issn>1382-6689</issn><eissn>1872-7077</eissn><abstract>Highlights • Migration, invasion and apoptosis of SGC7901 were inhibited by sorafenib. • Sorafenib treatment decreased phosphorylation activation of ERK protein. • Sorafenib increased pro-apoptosis protein expression. • ERK signals in SGC7901 are one of the mechanisms of sorafenib inhibiting gastric cancer.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>25136776</pmid><doi>10.1016/j.etap.2014.07.012</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1382-6689
ispartof Environmental toxicology and pharmacology, 2014-09, Vol.38 (2), p.438-443
issn 1382-6689
1872-7077
language eng
recordid cdi_proquest_miscellaneous_1609098765
source ScienceDirect Freedom Collection
subjects Antineoplastic Agents - pharmacology
Apoptosis
Cell cycle
Cell Line, Tumor
Cell Movement - drug effects
Cell Proliferation - drug effects
Emergency
ERK signal pathway
Gastric cancer
Gene Expression Regulation, Neoplastic - drug effects
Humans
MAP Kinase Signaling System - drug effects
Microcystis - metabolism
Niacinamide - analogs & derivatives
Niacinamide - pharmacology
Phenylurea Compounds - pharmacology
Phosphorylation - drug effects
Protein Kinase Inhibitors - pharmacology
SGC7901
Stomach Neoplasms - drug therapy
Stomach Neoplasms - genetics
title Sorafenib regulating ERK signals pathway in gastric cancer cell
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T04%3A57%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Sorafenib%20regulating%20ERK%20signals%20pathway%20in%20gastric%20cancer%20cell&rft.jtitle=Environmental%20toxicology%20and%20pharmacology&rft.au=Juan,%20Liu%20Wei&rft.date=2014-09-01&rft.volume=38&rft.issue=2&rft.spage=438&rft.epage=443&rft.pages=438-443&rft.issn=1382-6689&rft.eissn=1872-7077&rft_id=info:doi/10.1016/j.etap.2014.07.012&rft_dat=%3Cproquest_cross%3E1609098765%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c411t-453048551536de876f99ed51553f746aa322fc60efaa5351afb819be9e9085b03%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1609098765&rft_id=info:pmid/25136776&rfr_iscdi=true